Trial
NCT04702048
Evaluation of the Retina in Patients With Non-proliferative Diabetic Retinopathy After Aflibercept Injection in the Eye
Phase IVWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
University of Rochester
Collaborators
—
Condition
Retinopathy, Diabetic
Intervention
Aflibercept Injection
Why stopped
sponsor withdrew funding
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-05-05